AstraZeneca's AZD4954 Study Evaluates Safety and Pharmacokinetics in Healthy Adults
AstraZeneca is conducting a study to assess the safety, tolerability, PK, and PD of AZD4954 in healthy adults, including those with elevated Lp(a) levels.
Asset / Drug
Drug and asset intelligence for AZD4954 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.